BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 31396534)

  • 1. Biologics in the Treatment of Lupus Erythematosus: A Critical Literature Review.
    Samotij D; Reich A
    Biomed Res Int; 2019; 2019():8142368. PubMed ID: 31396534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the biologic therapy of lupus: the 10 most important areas to look for common pitfalls in clinical trials.
    Medina-Rosas J; Al-Rayes H; Moustafa AT; Touma Z
    Expert Opin Biol Ther; 2016 Oct; 16(10):1225-38. PubMed ID: 27429254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on Biologic Therapies for Systemic Lupus Erythematosus.
    Borba HH; Funke A; Wiens A; Utiyama SR; Perlin CM; Pontarolo R
    Curr Rheumatol Rep; 2016 Jul; 18(7):44. PubMed ID: 27299782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologic therapies in systemic lupus erythematosus.
    Bernal CB; Zamora LD; Navarra SV
    Int J Rheum Dis; 2015 Feb; 18(2):146-53. PubMed ID: 25884458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biologics in SLE: towards new approaches.
    van Vollenhoven RF; Parodis I; Levitsky A
    Best Pract Res Clin Rheumatol; 2013 Jun; 27(3):341-9. PubMed ID: 24238691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent developments in the treatment of patients with systemic lupus erythematosus: focusing on biologic therapies.
    Fattah Z; Isenberg DA
    Expert Opin Biol Ther; 2014 Mar; 14(3):311-26. PubMed ID: 24387632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus.
    Sthoeger Z; Sharabi A; Mozes E
    J Autoimmun; 2014 Nov; 54():60-71. PubMed ID: 24958634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologics in SLE: the current status.
    Rajadhyaksha AG; Mehra S; Nadkar MY
    J Assoc Physicians India; 2013 Apr; 61(4):262-7. PubMed ID: 24482965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons learned from the failure of several recent trials with biologic treatment in systemic lupus erythematosus.
    Hruskova Z; Tesar V
    Expert Opin Biol Ther; 2018 Sep; 18(9):989-996. PubMed ID: 30040494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current role of rituximab in systemic lupus erythematosus.
    Mok CC
    Int J Rheum Dis; 2015 Feb; 18(2):154-63. PubMed ID: 25522652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus.
    Jordan NP; D'Cruz DP
    Expert Opin Drug Metab Toxicol; 2015; 11(10):1635-45. PubMed ID: 26327145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Treatments in Lupus.
    Kyttaris VC
    Curr Rheumatol Rep; 2017 Mar; 19(3):10. PubMed ID: 28265845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on belimumab for the management of systemic lupus erythematosus.
    Lutalo PM; D'Cruz DP
    Expert Opin Biol Ther; 2014 Nov; 14(11):1701-8. PubMed ID: 25303323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biologics in SLE].
    Karonitsch T; Aringer M
    Wien Med Wochenschr; 2015 Jan; 165(1-2):40-5. PubMed ID: 25411010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR; Gordon C
    BioDrugs; 2013 Apr; 27(2):85-95. PubMed ID: 23456653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New biologic therapy for systemic lupus erythematosus.
    Ding HJ; Gordon C
    Curr Opin Pharmacol; 2013 Jun; 13(3):405-12. PubMed ID: 23664092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus.
    Bakshi J; Segura BT; Wincup C; Rahman A
    Clin Rev Allergy Immunol; 2018 Dec; 55(3):352-367. PubMed ID: 28853005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Belimumab for the treatment of systemic lupus erythematosus.
    Jordan N; D'Cruz DP
    Expert Rev Clin Immunol; 2015 Feb; 11(2):195-204. PubMed ID: 25543845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging therapies in systemic lupus erythematous: from clinical trial to the real life.
    Zhang H; Chambers W; Sciascia S; Cuadrado MJ
    Expert Rev Clin Pharmacol; 2016; 9(5):681-94. PubMed ID: 26907827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lupus clinical development: will belimumab's approval catalyse a new paradigm for SLE drug development?
    Runkel L; Stacey J
    Expert Opin Biol Ther; 2014 Apr; 14(4):491-501. PubMed ID: 24490627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.